Saram ConsultingGxP & AI Consulting for Life Sciences. Custom AI integrations, Part 11 compliance validation, and equity-based engineering partnerships for biotech.Explore Services at saram.io →
← Back to Home

Click Therapeutics

Private
#Digital Therapeutics#Neuroscience#Psychiatry#Schizophrenia#Migraine

Digital therapeutics company developing prescription software treatments for neuropsychiatric and neurological conditions, including schizophrenia, major depressive disorder and migraine.

Company Info

Sector:Digital Therapeutics
Headquarters:New York, NY, USA
Founded:2012
Website:www.clicktherapeutics.com/
Funding Round:Series D (with Boehringer Ingelheim)

Funding & Investor Relations

Notable Investors

  • Boehringer Ingelheim
  • Otsuka Pharmaceutical
  • H.I.G. BioHealth Partners

Clinical Development Pipeline

Motivista (CT-155)

Target: Cognitive and behavioral digital intervention
Negative symptoms of schizophrenia, adjunct to antipsychotics
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Rejoyn

Target: Prescription digital therapeutic (with Otsuka)
Major depressive disorder
Preclinical
Phase 1
Phase 2
Phase 3
Approved

CT-132

Target: Prescription digital therapeutic
Preventive treatment of episodic migraine
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Recent News

Leadership Team

David Benshoof Klein

Co-Founder and Chief Executive Officer

Wei Kiddy Zhou

Co-Founder

Careers & Job Openings

See all open roles

All
New York, NY
Apply Now →